Markets:

Overview

News

Currencies

International

Treasuries

Prime Medicine, Inc. - Common Stock (NQ:PRME)

3.380 -0.260 (-7.14%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prime Medicine, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline ↗

September 30, 2024

Prime Medicine enters a strategic collaboration with Bristol Myers Squibb to develop next-gen T-cell therapies, securing $110 million upfront with potential for $3.5 billion in milestones. The company...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

Prime Medicine Unveils Strategically Focused Pipeline

September 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine Announces Strategic Research Collaboration and License Agreement with Bristol Myers Squibb to Develop and Commercialize Multiple Prime Edited Ex Vivo T-Cell Therapies

September 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Recap: Prime Medicine Q4 Earnings ↗

March 01, 2024

Via Benzinga

2 Growth Stocks That Could Make You Richer ↗

August 28, 2024

Discover two cutting-edge growth stocks that could revolutionize medicine and space exploration.

Via The Motley Fool

Prime Medicine to Participate in Upcoming Investor Conferences

August 28, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

PRME Stock Earnings: Prime Medicine Misses EPS for Q2 2024 ↗

August 08, 2024

PRME stock results show that Prime Medicine missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates

August 08, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine to Present at Upcoming Investor Conferences

May 30, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names ↗

May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

Via InvestorPlace

Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio ↗

May 25, 2024

Alphabet may have strong insight into both company's industries.

Via The Motley Fool

Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 ↗

May 17, 2024

Discover three biotech stocks handpicked by Cathie Wood, offering groundbreaking therapies and substantial growth potential.

Via InvestorPlace

Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024 ↗

May 17, 2024

With new innovation, millions of retiring baby boomers, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead.

Via InvestorPlace

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024 ↗

May 10, 2024

PRME stock results show that Prime Medicine beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

May 10, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

May 08, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket ↗

May 02, 2024

Via Benzinga

Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference

May 01, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 29, 2024

Via Benzinga

Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday ↗

April 29, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 29, 2024

Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!

Via InvestorPlace

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

April 29, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 26, 2024

Via Benzinga

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

April 23, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

2 Magnificent Growth Stocks With Room to Run ↗

March 27, 2024

These deeply undervalued growth stocks could be big winners for patient shareholders.

Via The Motley Fool

Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging ↗

March 14, 2024

Explore short-squeeze stocks for potential surges, spotlighting investor strategies and trends that could benefit your portfolio.

Via InvestorPlace

Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too? ↗

March 01, 2024

On the leading edge of rare disease treatment and therapy is where you will find these Cathie Wood biotech stocks.

Via InvestorPlace

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

March 01, 2024

From Prime Medicine, Inc.

Via GlobeNewswire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.